{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:33:01Z","timestamp":1780353181950,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.saa.2019.02.071","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T16:55:29Z","timestamp":1550508929000},"page":"399-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A new sensitive approach for spectrofluorimetric assay of Milnacipran and Amisulpride in real plasma and pharmaceutical preparations via complexation with Eosin Y dye"],"prefix":"10.1016","volume":"214","author":[{"given":"Noha N.","family":"Atia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Marzouq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid E.","family":"Eltoukhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2019.02.071_bb0005","series-title":"Lippincott's Illustrated Reviews: Pharmacology","author":"Harvey","year":"2012"},{"key":"10.1016\/j.saa.2019.02.071_bb0010","first-page":"655","article-title":"Martindale: the complete drug reference. 38th ed","volume":"2","author":"Bayer","year":"2015","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.saa.2019.02.071_bb0015","series-title":"Illustrated Medical Dictionary","first-page":"166","author":"T.B.M. Association","year":"2002"},{"key":"10.1016\/j.saa.2019.02.071_bb0020","series-title":"Conquering Depression","first-page":"120","author":"Khandelwal S","year":"2001"},{"key":"10.1016\/j.saa.2019.02.071_bb0025","series-title":"Her Majesty's Stationary Office, UK, London","author":"British Pharmacopoeia","year":"2016"},{"key":"10.1016\/j.saa.2019.02.071_bb0030","first-page":"1175","article-title":"New spectrophotometric methods for the determination of amisulpride in pharmaceutical dosage forms","volume":"26","author":"Venumadhav","year":"2010","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.saa.2019.02.071_bb0035","first-page":"206","article-title":"Simple and facile spectrophotometric methods for the determination of amisulpride in pharmaceutical formulations","volume":"60","author":"Satyanarayana","year":"2012","journal-title":"J. Farmacia"},{"key":"10.1016\/j.saa.2019.02.071_bb0040","first-page":"4830","article-title":"Novel spectrophotometric methods for the determination of Amisulpridein pure and pharmaceutical formulations","volume":"6","author":"Ravisankar","year":"2015","journal-title":"Int. J. Recent Sci. Res."},{"key":"10.1016\/j.saa.2019.02.071_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12691\/ces-1-1-1","article-title":"Quantitative determination of Milnacipran by simple colorimetric methods","volume":"1","author":"Mubarakunnisa","year":"2013","journal-title":"J. Chem. Eng. Sci."},{"key":"10.1016\/j.saa.2019.02.071_bb0050","first-page":"88","article-title":"Spectrophotometric determination of drugs in bulk and tablet form by using 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone","volume":"5","author":"Srinivas","year":"2015","journal-title":"J. Anal. Bioanal. Chem"},{"key":"10.1016\/j.saa.2019.02.071_bb0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11094-016-1449-3","article-title":"Simple and sensitive colorimetric method for the determination of Milnacipran in bulk and swellable matrix tablets","volume":"50","author":"Hussain","year":"2016","journal-title":"J. Pharm. Chem."},{"key":"10.1016\/j.saa.2019.02.071_bb0060","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/bio.2673","article-title":"Spectrofluorimetric determination of amisulpride and bumidazone in raw materials and tablets","volume":"29","author":"Walash","year":"2014","journal-title":"J. Lumin."},{"key":"10.1016\/j.saa.2019.02.071_bb0065","first-page":"1909","article-title":"Isocratic liquid chromatographic method for analysis of amisulpride in pharmaceutical preparations","volume":"3","author":"Neog","year":"2011","journal-title":"Int. J. Pharm. Technol. Res."},{"key":"10.1016\/j.saa.2019.02.071_bb0070","first-page":"583","article-title":"Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study","volume":"79","author":"Mogili","year":"2011","journal-title":"J. Sci. Pharm."},{"key":"10.1016\/j.saa.2019.02.071_bb0075","first-page":"220","article-title":"Stability-indicating HPLC method for Milnacipran hydrochloride in bulk and pharmaceutical dosage forms","volume":"1","author":"Reddy","year":"2013","journal-title":"J. Technol. Sci."},{"key":"10.1016\/j.saa.2019.02.071_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10826076.2012.734002","article-title":"Quantitative determination OF Milnacipran HCL in rabbit plasma by HPLC and its application to pharmacokinetics study","volume":"37","author":"Parejiya","year":"2014","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.saa.2019.02.071_bb0085","first-page":"579","article-title":"Ion selective membrane electrodes for stability-indicating determination of amisulpride","volume":"4","author":"AbdElHamid","year":"2012","journal-title":"J. Anal. Bioanal. Electrochem."},{"key":"10.1016\/j.saa.2019.02.071_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jpha.2013.03.009","article-title":"Bioanalytical method development and validation of milnacipran in rat plasma by LC\u2013MS\/MS detection and its application to a pharmacokinetic study","volume":"3","author":"Kanala","year":"2013","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.saa.2019.02.071_bb0095","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/bmc.1530","article-title":"Basic drug analysis by strong cation-exchange liquid chromatography\u2013tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum\/plasma","volume":"25","author":"Couchman","year":"2011","journal-title":"J. Biomed. Chromatogr."},{"key":"10.1016\/j.saa.2019.02.071_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1365\/s10337-010-1607-9","article-title":"Determination of milnacipran in human plasma using GC\u2013MS","volume":"72","author":"U\u00e7akt\u00fcrk","year":"2010","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.saa.2019.02.071_bb0105","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.14233\/ajchem.2013.13716","article-title":"Spectrophotometric determination of nor-epinephrine serotonin reuptake inhibitor (SNRI) drug Milnacipran in pure and in dosage forms","volume":"25","author":"Singhvi","year":"2013","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.saa.2019.02.071_bb0110","first-page":"2","article-title":"Validation of rapid and sensitive spectrofluorimetric assay for determination of four triptans in pure and dosage forms; application to human plasma and content uniformity testing","volume":"7","author":"Hammad","year":"2016","journal-title":"J. Pharm. Anal. Acta"},{"key":"10.1016\/j.saa.2019.02.071_bb0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0731-7085(95)01662-7","article-title":"Spectrophotometric and spectrofluorimetric estimation of ciprofloxacin and norfloxacin by ternary complex formation with eosin and palladium (II)","volume":"14","author":"El Walily","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2019.02.071_bb0120","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/jaoac\/91.6.1309","article-title":"Spectrofluorometric determination of olanzapine and fluphenazine hydrochloride in pharmaceutical preparations and human plasma using eosin: application to stability studies","volume":"91","author":"Belal","year":"2008","journal-title":"Int. J. AOAC"},{"key":"10.1016\/j.saa.2019.02.071_bb0125","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1039\/C3AY41371C","article-title":"An application of eosin Y for the selective spectrophotometric and spectrofluorimetric determination of mebeverine hydrochloride","volume":"6","author":"Derayea","year":"2014","journal-title":"J. Anal. Methods"},{"key":"10.1016\/j.saa.2019.02.071_bb0130","doi-asserted-by":"crossref","first-page":"S541","DOI":"10.1016\/j.arabjc.2011.06.021","article-title":"Determination of clemastine hydrogen fumarate, desloratadine, losartan potassium and moxepril HCl through binary complex formation with eosin","volume":"9","author":"El-Hay","year":"2016","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.saa.2019.02.071_bb0135","series-title":"Colorimetric and Fluorometric Analysis of Organic Compounds and Drugs","first-page":"623","author":"Pesez","year":"1974"},{"key":"10.1016\/j.saa.2019.02.071_bb0140","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1208\/s12249-013-9969-6","article-title":"Highly sensitive spectrofluorimetric method for determination of certain aminoglycosides in pharmaceutical formulations and human plasma","volume":"14","author":"Omar","year":"2013","journal-title":"J. Pharm Sci. Technol."},{"key":"10.1016\/j.saa.2019.02.071_bb0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpba.2018.01.038","article-title":"Ultrasensitive spectrofluorimetric method for rapid determination of daclatasvir and ledipasvir in human plasma and pharmaceutical formulations","volume":"152","author":"Abo-Zeid","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2019.02.071_bb0150","series-title":"Handbook of Biological Dyes and Stains: Synthesis and Industrial Applications","author":"Sabnis","year":"2010"},{"key":"10.1016\/j.saa.2019.02.071_bb0155","series-title":"Modern Analytical Chemistry","author":"Harvey","year":"2000"},{"key":"10.1016\/j.saa.2019.02.071_bb0160","first-page":"11","article-title":"Validation of Analytical Procedures: Text and Methodology Q2 (R1)","author":"Guideline","year":"2005"},{"key":"10.1016\/j.saa.2019.02.071_bb0165","series-title":"Statistics and Chemometrics for Analytical Chemistry, Harlow","author":"Miller","year":"2005"},{"key":"10.1016\/j.saa.2019.02.071_bb0170","first-page":"53","article-title":"Development and validation of UV spectrophotometric method for determination of milnacipran in bulk and pharmaceutical dosage form","volume":"6","author":"Parejiya","year":"2011","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.saa.2019.02.071_bb0175","series-title":"The United States Pharmacopoeia., XXVIIII and NF XXV","volume":"2012","author":"Pharmacopoeia","year":"2012"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519301933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519301933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T02:10:42Z","timestamp":1606529442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142519301933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":35,"alternative-id":["S1386142519301933"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2019.02.071","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new sensitive approach for spectrofluorimetric assay of Milnacipran and Amisulpride in real plasma and pharmaceutical preparations via complexation with Eosin Y dye","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2019.02.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}